Drugs / sofosbuvir/ledipasvir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02717949 | Feb 2016 → Jun 2017 | liver disorder | University of Texas Southwestern Medical Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sofosbuvir/ledipasvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02717949 ↗ |
| Route | Oral | “given once a day by mouth” NCT02717949 ↗ |